Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dutta, S. Articles by Clemens, J. D. Search for Related Content PubMed PubMed Citation Articles by Dutta, S. Articles by Clemens, J. D.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2005, p. 1662-1663, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1662-1663.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Rollback of Salmonella enterica Serotype Typhi Resistance to Chloramphenicol and Other Antimicrobials in Kolkata, India

Top Letter References

 
Multidrug-resistant (MDR) Salmonella enterica serotype Typhi created a significant therapeutic problem in the late 1980s and early 1990s (1, 7, 8). As serotype Typhi strains were resistant to commonly used antimicrobials for the treatment of typhoid fever, such as ampicillin, amoxicillin, chloramphenicol, and cotrimoxazole, ciprofloxacin began to be used widely for MDR typhoid fever (2). But after some years, decreased clinical responsiveness of typhoid fever cases to ciprofloxacin was observed. Ceftriaxone continues to be uniformly effective against typhoid fever, including cases in which ciprofloxacin treatment has failed (3). The purpose of the study was to compare the antimicrobial resistance patterns of Salmonella enterica serotype Typhi strains isolated from typhoid fever cases in Kolkata, India over the past few years.

From 1 May 2003 to 31 July 2004, as part of a prospective surveillance for typhoid fever in two urban slums in Kolkata (formerly Calcutta), a total of 4,400 blood samples were collected in BACTEC culture vials (Becton Dickinson) from patients with fever lasting 3 or more days. Incubation and identification of organisms were carried out according to conventional procedures. Serotype Typhi was isolated from 132 (3%) of the samples collected and processed. The antimicrobial susceptibility of the serotype Typhi isolates was determined by the Kirby-Bauer disk diffusion technique, and the MICs were determined by the E test (AB Biodisk, Solna, Sweden). The following resistance pattern of serotype Typhi strains was observed: chloramphenicol, 13%; ampicillin, 13%; amoxicillin-clavulanic acid, 0%; cotrimoxazole, 15%; ciprofloxacin, 10%; ofloxacin, 2%; and ceftriaxone, 0%. We compared our present observations with those from previous years (Table 1). The chi-square test was used to compare the pro-portion of resistant isolates. A significant decrease over the years in resistance to chloramphenicol, ampicillin, and cotrimoxazole was noticed (P < 0.0001).

View this table: [in this window] [in a new window]

TABLE 1. Antimicrobial resistance pattern of Salmonella enterica serotype Typhi, Kolkata, Indiaa

Our findings indicate a remarkable reversal in the resistance pattern of serotype Typhi in Kolkata since the early 1990s. This reversal may be due to the emergence of de novo susceptible strains or the loss of a high-molecular-weight self-transferable plasmid encoding chloramphenicol, ampicillin, and cotrimoxazole resistance in recently isolated serotype Typhi strains (5). There are reports which indicate the coexistence of antibiotic-sensitive and MDR serotype Typhi strains as distinct independent clones (4, 10). The MDR serotype Typhi isolates may also belong to different pulsed-field gel electrophoresis genotypes (6) or emerge from a single clone (9). In the present study, molecular characterization of the isolated strains was not carried out. The change in the resistance patterns of chloramphenicol, ampicillin, and cotrimoxazole is noteworthy and calls for future studies to determine molecular relatedness of or differences between the present and past strains and possible loss of the resistance plasmid.

It may be concluded that this new information could help clinicians to decide on the drug of choice for the treatment of typhoid fever. Chloramphenicol and other antimicrobials may be of use again. The emergence of isolates resistant to ciprofloxacin and ofloxacin suggests that if present use remains unchanged, it is probably only a matter of time before the organisms develop widespread resistance to the fluoroquinolones.

 
We thank all technical staff and research assistants associated with the study.  The Bill and Melinda Gates Foundation provided financial support through the Diseases of Most Impoverished Program administered by the International Vaccine Institute, Seoul, Korea.

Top Letter References

 

1
1. Anand, A. C., V. K. Kataria, W. Singh, and S. K. Chatterjee. 1990. Epidemic multiresistant enteric fever in eastern India. Lancet 335:352. (Letter.)[CrossRef][Medline]
2
2. Asperilla, M. O., R. A. Smego, and L. K. Scott. 1990. Quinolone antibiotics in the treatment of Salmonella infections. Rev. Infect. Dis. 12:873.[Medline]
3
3. Dutta, P., U. Mitra, S. Datta, M. R. Saha, A. De, K. Roy, M. Basak, and S. K. Bhattacharya. 2001. Ciprofloxacin susceptible Salmonella typhi with treatment failure. J. Trop. Pediatr. 47:252-253.[Free Full Text]
4
4. Jesudasan, M. V., R. John, and T. J. John. 1996. The concurrent prevalence of chloramphenicol sensitive and multidrug resistant Salmonella typhi in Vellore, S. India. Epidemiol. Infect. 116:225-227.
5
5. Karmakar, S., D. Biswas, N. M. Shaikh, S. K. Chatterjee, V. K. Kataria, and R. Kumar. 1991. Role of large plasmid of Salmonella typhi encoding multiple drug resistance. J. Med. Microbiol. 34:149-151.[Abstract/Free Full Text]
6
6. Mirza, S., S. Kariuki, K. Z. Mamun, N. J. Beeching, and C. A. Hart. 2000. Analysis of plasmid and chromosomal DNA of multidrug-resistant Salmonella enterica serovar Typhi from Asia. J. Clin. Microbiol. 38:1449-1452.[Abstract/Free Full Text]
7
7. Rasaily, R., P. Dutta, M. R. Saha, U. Mitra, M. Lahiri, and S. C. Pal. 1994. Multidrug resistant typhoid fever in hospitalised children: clinical, bacterio-logical and epidemiological profiles. Eur. J. Epidemiol. 10:41-46.[CrossRef][Medline]
8
8. Saha, M. R., P. Dutta, S. K. Bhattacharya, R. Rasaily, U. Mitra, D. Dutta, M. K. Bhattacharya, and S. C. Pal. 1992. Occurrence of multidrug resistant Salmonella typhi in Calcutta. Indian J. Med. Res. 95:179-180.[Medline]
9
9. Shanahan, P. M., M. V. Jesudasan, C. J. Thomson, and S. G. Amyes. 1998. Molecular analysis of and identification of antibiotic resistance genes in clinical isolates of Salmonella typhi from India. J. Clin. Microbiol. 36:1595-1600.[Abstract/Free Full Text]
10
10. Thong, K. L., Z. A. Bhutta, and T. Pang. 2000. Multidrug-resistant strains of Salmonella enterica serotype Typhi are genetically homogenous and coexist with antibiotic sensitive strains as distinct, independent clones. Int. J. Infect. Dis. 4:194-197.[CrossRef][Medline]

						Shanta Dutta Dipika Sur Byomkesh Manna Sujit K. Bhattacharya* National Institute of Cholera and Enteric Diseases P-33 Cit Rd., Scheme XM Kolkata, India Jacqueline L. Deen John D. Clemens International Vaccine Institute Seoul, Korea
						* Phone: 91-33-23501176, Fax: 91-33-2350-5066, Email: sujitkbhattacharya{at}yahoo.com

---

Antimicrobial Agents and Chemotherapy, April 2005, p. 1662-1663, Vol. 49, No. 4
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.4.1662-1663.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Thaver, D., Zaidi, A. K M, Critchley, J., Azmatullah, A., Madni, S. A., Bhutta, Z. A (2009). A comparison of fluoroquinolones versus other antibiotics for treating enteric fever: meta-analysis. BMJ 338: b1865-b1865 [Abstract] [Full Text]  
• Phan, M.-D., Kidgell, C., Nair, S., Holt, K. E., Turner, A. K., Hinds, J., Butcher, P., Cooke, F. J., Thomson, N. R., Titball, R., Bhutta, Z. A., Hasan, R., Dougan, G., Wain, J. (2009). Variation in Salmonella enterica Serovar Typhi IncHI1 Plasmids during the Global Spread of Resistant Typhoid Fever. Antimicrob. Agents Chemother. 53: 716-727 [Abstract] [Full Text]  
• Chau, T. T., Campbell, J. I., Galindo, C. M., Van Minh Hoang, N., Diep, T. S., Nga, T. T. T., Van Vinh Chau, N., Tuan, P. Q., Page, A. L., Ochiai, R. L., Schultsz, C., Wain, J., Bhutta, Z. A., Parry, C. M., Bhattacharya, S. K., Dutta, S., Agtini, M., Dong, B., Honghui, Y., Anh, D. D., Canh, D. G., Naheed, A., Albert, M. J., Phetsouvanh, R., Newton, P. N., Basnyat, B., Arjyal, A., La, T. T. P., Rang, N. N., Phuong, L. T., Van Be Bay, P., von Seidlein, L., Dougan, G., Clemens, J. D., Vinh, H., Hien, T. T., Chinh, N. T., Acosta, C. J., Farrar, J., Dolecek, C. (2007). Antimicrobial Drug Resistance of Salmonella enterica Serovar Typhi in Asia and Molecular Mechanism of Reduced Susceptibility to the Fluoroquinolones. Antimicrob. Agents Chemother. 51: 4315-4323 [Abstract] [Full Text]  

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dutta, S. Articles by Clemens, J. D. Search for Related Content PubMed PubMed Citation Articles by Dutta, S. Articles by Clemens, J. D.